First investigations for the characterization of glucosamine-6- 1 phosphate synthase by capillary electrophoresis by Beneito-Cambra, Miriam et al.
HAL Id: hal-02329349
https://hal.archives-ouvertes.fr/hal-02329349
Submitted on 23 Oct 2019
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
First investigations for the characterization of
glucosamine-6- 1 phosphate synthase by capillary
electrophoresis
Miriam Beneito-Cambra, Pierre Gareil, Bernard Badet, Marie-Ange
Badet-Denisot, Nathalie Delaunay
To cite this version:
Miriam Beneito-Cambra, Pierre Gareil, Bernard Badet, Marie-Ange Badet-Denisot, Nathalie Delau-
nay. First investigations for the characterization of glucosamine-6- 1 phosphate synthase by capillary
electrophoresis. Journal of Chromatography B Biomedical Sciences and Applications, Elsevier, 2018,
1072, pp.130-135. ￿10.1016/j.jchromb.2017.11.015￿. ￿hal-02329349￿
1 
 
First investigations for the characterization of glucosamine-6-1 
phosphate synthase by capillary electrophoresis 2 
 3 
Miriam Beneito-Cambra
a
, Pierre Gareil
b
, Bernard Badet
c
, Marie-Ange Badet-Denisot
c
, 4 
Nathalie Delaunay
a,d
*  5 
 6 
a
Laboratory of Analytical and Bioanalytical Sciences and Miniaturization, UMR CBI 7 
8231, ESPCI Paris, PSL Research University, 10 rue Vauquelin, 75005 Paris, France 8 
b
Chimie ParisTech, Laboratory of Physicochemistry of Electrolytes, Colloids and 9 
Analytical Sciences (PECSA), 75005 Paris, France 10 
c
Centre de recherche de Gif, Institut de Chimie des Substances Naturelles, CNRS, 11 
Avenue de la Terrasse, 91198 Gif-sur-Yvette cedex, France 12 
d
CNRS, UMR 8231, Paris, France 13 
 14 
Corresponding author: Nathalie Delaunay, ESPCI Paris, Laboratory of Analytical and 15 
Bioanalytical Sciences and Miniaturization, UMR CBI 8231, 10 rue Vauquelin, 75231 16 
Paris cedex 05, France. Tel: +33 140794651. Fax: +33 140794776.  17 
e-mail adress: nathalie.delaunay@espci.fr 18 
 19 
 20 
 21 
 22 
 23 
24 
2 
 
ABSTRACT 25 
The enzyme glucosamine-6-phosphate synthase (GlmS) is an important point of 26 
metabolic control in biosynthesis of amino sugar-containing macromolecules and is 27 
therefore a potential target in order to design antibacterial and antifungal drugs. It has 28 
two oligomerization states, which are the active dimer and the inactive hexamer. For the 29 
first time, the potential of CE to separate and quantify the two forms was studied. After 30 
incubating GlmS with the D-glucosamine 6-phosphate (GlcN6P) inhibitor, an 31 
electrolyte based on sodium phosphate at pH 7.2 and an ionic strength of 100 mM plus 32 
GlcN6P (either 2 or 20 mM) allowed the hexamer-dimer separation. However, the 33 
displacement of the dimer/hexamer equilibrium during the analysis time prevented any 34 
improvement of the resolution when varying the effective separation length or the 35 
temperature of the analysis. Therefore, the use of a short-end CE method allowed the 36 
decrease in the analysis time to about 1 min. Some parameters such as the temperature 37 
and the time of incubation and the ratio of the inhibitor and enzyme concentrations were 38 
studied. Then, it was also possible to test, very rapidly and with a very small amount, 39 
some molecules having an inhibition potential for the GlmS enzyme (arabinose-5-40 
phosphate oxime, 2-amino-2-deoxy-D-glucitol 6-phosphate, and glucose-6-phosphate). 41 
 42 
 43 
Keywords: capillary electrophoresis; enzyme; glucosamine-6-phosphate synthase; 44 
inhibitor screening 45 
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Abbreviations 47 
ADGP: 2-amino-2-deoxy-D-glucitol 6-phosphate, A5PO: arabinose-5-phosphate oxime, 48 
BGE: background electrolyte, BTP: Bis Tris Propane, DTT: dithiothreitol, EDTA: 49 
ethylenediaminetetraacetic acid, Glc6P: glucose-6-phosphate, GlcN6P: D-glucosamine 50 
6-phosphate, GlmS: glucosamine-6-phosphate synthase, PTSA: p-toluenesulfonic acid. 51 
52 
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1. Introduction 53 
 54 
The enzyme glucosamine-6-phosphate synthase (GlmS) is an important point of 55 
metabolic control in the biosynthesis of amino sugar-containing macromolecules [1-2]. 56 
Indeed, it catalyzes the first step of the hexosamine metabolism since it irreversibly 57 
converts D-fructose-6-phosphate into D-glucosamine 6-phosphate (GlcN6P) using L-58 
glutamine as a nitrogen source. The end product, uridine diphosphate N-59 
acetylglucosamine-6-phosphate, is an essential building block of bacterial and fungal 60 
cell walls. Therefore, GlmS is a potential target in the design of antibacterial and 61 
antifungal drugs [1-3], which is a major issue because invasive fungal infections have 62 
increased dramatically over the past two decades and are associated with an increase in 63 
morbidity and mortality [4]. Moreover, as GlmS leads to compounds belonging to 64 
glycosylation pathways potentially implicated in the regulation of glucose, it is also a 65 
therapeutic target to prevent from complications in type-2 diabetes [1, 2].  66 
The active form of GlmS from Escherichia coli is a dimeric assembly of two identical 67 
monomers, each consisting of a 27 kDa glutaminase domain and a 40 kDa synthase 68 
domain [1, 2]. A study using size exclusion chromatography, dynamic and quasi-elastic 69 
light scattering, native polyacrylamide gel electrophoresis, and ultracentrifugation 70 
demonstrated that the dimer is in equilibrium with a hexameric form, in vitro as well as 71 
in cellulo [5]. Moreover, the enzyme crystal structure studies allowed the identification 72 
of two enzyme conformations, which are the dimer and the hexamer. It was also 73 
observed that increasing the protein concentration results in a decrease in enzyme 74 
specific activity and that the presence of GlcN6P favours the hexameric form. Both 75 
effects strongly supported GlmS inhibition through hexamer stabilization, which would 76 
reflect a physiologically relevant allosteric regulation of E. coli enzyme. In addition to 77 
glucose 6-phosphate bound at the active site, the crystallographic hexameric 78 
organization of E. coli GlmS enables the binding of another linear sugar. Keeping this 79 
binding site occupied should then force the GlmS to remain in the inactive hexamer 80 
state, which should be useful for the development of specific inhibitors. 81 
The product GlcN6P with weak inhibitory properties (Ki = 0.38 mM) was the first 82 
studied GlmS inhibitor [1]. Other reported inhibitors, such as arabinose-5-phosphate 83 
oxime (A5PO) (Ki = 14 μM) and 2-amino-2-deoxy-D-glucitol 6-phosphate (ADGP) (Ki 84 
= 25 μM), which exhibit better inhibition properties are good candidates for the 85 
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hexamer stabilization [3]. The potential use of GlmS as a therapeutic target is likely to 86 
explain the sustained interest in the synthesis of new GlmS inhibitors [6,7]. 87 
Different methods were described in the literature to determine the GlmS activity, such 88 
as the Morgan-Elson colorimetric assay, the continuous coupled assay or the 89 
radiometric assay employing [
14
C]Fructose-6-phospate and involving an electrophoretic 90 
separation of formed [
14
C]GlcN6P [1]. They all involve several laborious steps. More 91 
recently, new alternatives were proposed such as isothermal titration calorimetry [8] and 92 
matrix-assisted laser desorption/ionization time-of-flight mass spectrometry [9]. 93 
Separation techniques, such as high performance liquid chromatography (HPLC), could 94 
also be a valuable alternative. Indeed, HPLC allowed the study of the enzyme activity or 95 
the screening of inhibitors thanks to the separation of the substrates or the products 96 
followed by spectrophotometry [10, 11] or mass spectrometry detection [12].  97 
In the last two decades, capillary electrophoresis (CE) has become a powerful technique 98 
for the study of enzymes [13-17]. Indeed, CE is a powerful miniaturized separation 99 
technique that combines a short analysis time, high resolutions, a low cost, and a low 100 
sample and reagent consumption. In this study, for the first time, the potential of CE is 101 
evaluated for the measurement of the GlmS activity via the simultaneous determination 102 
of its active dimer and inactive hexamer forms after a pre-incubation with an inhibitor. 103 
The commercially available GlcN6P was used to develop the CE separation, as it was 104 
previously observed that the addition of 20 mM of GlcN6P to a 15 µM GlmS solution 105 
(about 1 mg mL
-1
) led to an equilibrium between the dimer and the hexamer [5]. 106 
GlcN6P was added to the GlmS sample before injection in the CE capillary, but also in 107 
the background electrolyte (BGE) to maintain the equilibrium between both forms. The 108 
CE method was also used to investigate the effect of the incubation time, the incubation 109 
temperature, and the concentration ratio of inhibitor and GlmS on the dimer/hexamer 110 
ratio. Finally, the method was evaluated for inhibitor screening with A5PO, ADGP, and 111 
glucose-6-phosphate (Glc6P). 112 
 113 
 114 
2. Materials and methods 115 
 116 
2.1 Chemical and reagents 117 
 118 
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1 M NaOH solution was from VWR (Fontenay-sous-Bois, France). Acetone (99.9%), 119 
HEPES (99.5%), GlcN6P monobasic (99%), sodium dihydrogen phosphate (98%), 120 
sodium hydrogen phosphate (99.0%), NaCl, Bis Tris Propane (BTP), 121 
ethylenediaminetetraacetic acid (EDTA), dithiothreitol (DTT), D-arabinose-5-phosphate 122 
disodium, hydroxylamine, p-toluenesulfonic acid (PTSA), and Glc6P were purchased 123 
from Sigma-Aldrich (Saint-Quentin-Fallavier, France). Ultrapure (UP) water was 124 
delivered by a Direct-Q3 system (Millipore, Molsheim, France).  125 
GlmS was purified from E. coli cells at 4°C with an anion exchange column (Q 126 
Sepharose) with a linear gradient from 0 to 1 M NaCl in a 20 mM BTP, 1 mM EDTA, 127 
and 1 mM DTT buffer at pH 7.2 [18]. The fractions containing GlmS were pooled, 128 
concentrated by ultrafiltration (30 kDa, Amicon-Ultra Centrifugal Filter Unit, Millipore) 129 
and purified with a Superdex 200 gel filtration column (Sigma-Aldrich) and a 50 mM 130 
HEPES buffer at pH 7.2 containing 1 mM of EDTA. The collected fractions were 131 
concentrated by ultrafiltration (30 kDa Amicon-Ultra). The purity of the isolated GlmS 132 
was checked by SDS-PAGE with a protocol already described [18]. A dialysis was 133 
carried out in order to reduce the concentrations of HEPES and NaCl. Finally, a stock 134 
solution of GlmS at 25.5 g L
-1
 (0.38 mM) in 50 mM HEPES and 50 mM NaCl buffer at 135 
pH 7.2 was obtained and kept at -20°C until use. A5PO was obtained from the reaction 136 
of the commercially available arabinose-5- phosphate with hydroxylamine [19]. ADGP 137 
was obtained by sodium borohydride reduction of GlcN6P [20]. 138 
 139 
2.2 Instrumentation 140 
 141 
The CE experiments were carried out with an Agilent Technologies 7100 CE system 142 
(Massy, France) equipped with a photodiode array absorbance detector. The UV 143 
detector was set at 270 nm for the neutral marker (acetone) and between 192 and 144 
200 nm for the GlmS enzyme. The data acquisition and the instrument control were 145 
carried out with the Chemstation software. The separations were performed with bare 146 
fused-silica capillaries (Photonlines, Marly-le-Roi, France) of 50 μm internal diameter 147 
and a total length of 35 or 58.5 cm (effective length 8.5, 26.5 or 50 cm, respectively).  148 
 149 
2.3 Electrophoretic conditions 150 
 151 
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New capillaries were activated by successive flushes under ca. 1 bar with 1 M NaOH, 152 
0.1 M NaOH, and water (10 min each, about 300 capillary volumes). Before each run, 153 
the capillary was rinsed with 0.1 M NaOH, UP water (5 min each one), and the 154 
appropriate BGE for 10 min. The appropriate amounts of GlcN6P, sodium dihydrogen 155 
phosphate, and sodium hydrogen phosphate were used to obtain the composition, pH, 156 
and ionic strength of the different tested BGEs. The GlcN6P pKa values of 6.2 and 8.2 157 
were used to make the calculations. The solutions of GlmS at concentration of 158 
0.05 mg/mL (0.76 μM), 0.13 g L-1 (1.9 μM), 0.25 g L-1 (3.8 μM) and 0.51 g L-1 159 
(7.6 μM) were prepared by dilution of the GlmS stock solution in the appropriate BGE. 160 
A dilution of acetone in the BGE (4%, v/v) was used as neutral marker. The solutions of 161 
GlmS and neutral marker were separately hydrodynamically injected, in two successive 162 
plugs but analyzed in the same run, to avoid any enzyme denaturation or other 163 
interference phenomenon. 164 
 165 
3. Results and discussion 166 
 167 
3.1 Development of the CE method 168 
 169 
A 100 mM phosphate buffer at pH 7.2 was selected as BGE in order to study the 170 
activity of the GlmS enzyme with a physiological environment. At pH 7.2, GlmS is 171 
expected to be negatively charged, as its isoelectric point value is 5.6 [21]. First, the 172 
GlmS electrophoretic profile was obtained with this phosphate buffer-based BGE, 173 
without adding the GlcN6P inhibitor in the sample and in the BGE. As shown in Figure 174 
1a, 4 peaks appeared in the electropherogram. The migration time of the neutral marker 175 
(see the dotted electropherogram) is about 4 min. Consequently, the main peak with a 176 
migration time of 5.9 min corresponds to an anion, as expected for GlmS at pH 7.2. 177 
Since the enzyme is initially present in the dimer form [1, 2], the main peak was 178 
assigned to the GlmS dimer. The first two peaks with migration times of about 4 min, 179 
corresponding to the migration time of the neutral marker, may correspond to neutral 180 
impurities present in the enzyme solution. The peak with a migration time of 4.8 min 181 
was assigned to HEPES, which is present in the GlmS stock solution. This hypothesis 182 
was confirmed by the CE analysis of an aliquot of 0.3 mM HEPES diluted in the 183 
phosphate-based BGE (data not shown).  184 
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Figure 1: Electrophoretic profiles of the GlmS enzyme (7.6 μM) (a) without or (b) with 186 
the addition of the GlcN6P inhibitor in the sample (incubation at room temperature) and 187 
in the BGE. In (a), the dotted line corresponds to the injection of the neutral marker 188 
(acetone). In (b), the concentration of the GlcN6P inhibitor was 20 mM and the 189 
incubation time was (b1) 10 min, (b2) 50 min, and (b3) 100 min. Electrophoretic 190 
conditions: bare-fused silica capillary, 50 μm × 35 cm (26.5 cm to the detection). BGE: 191 
(a) sodium phosphate buffer at pH 7.2 (100 mM ionic strength) and (b) sodium 192 
phosphate buffer at pH 7.2 plus 20 mM GlcN6P (100 mM ionic strength). Separation 193 
voltage: 10 kV (operating current: 50 µA). Analysis temperature: 20°C. Hydrodynamic 194 
injection: 30 mbar × 4 s. UV detection at 200 ± 10 nm for GlmS and 270 ± 10 nm for 195 
the neutral marker. 196 
 197 
In order to obtain the GlmS hexamer form, the enzyme was incubated for a given time 198 
in a vial containing the phosphate-based BGE plus 20 mM of GlcN6P and next injected 199 
in the CE system, using the incubation media as BGE to maintain the hexamer forms 200 
during the analysis [22]. As can be seen Figure 1b, the presence of GlcN6P led to the 201 
8 
 
appearance of an additional peak with a slightly higher migration time than that of the 202 
dimer peak. In addition, the intensity of this new peak increases with the incubation 203 
time, while the peak assigned to the dimer decreases. The UV spectrum of this new 204 
peak was recorded and it was similar to the spectrum obtained for the dimer (data not 205 
shown). Accordingly this new peak was assigned to the hexamer form. 206 
A higher migration time for the hexamer GlmS form than for the dimer form is 207 
consistent with the expected migration order due to an increase in charge to 208 
hydrodynamic size ratio from the dimer to the hexamer form due to a higher 209 
compactness, leading to a slight increase in the electrophoretic mobility (absolute value) 210 
for the hexamer. In the counter-electroosmotic flow mode, this resulted in an increase in 211 
the migration time.  212 
 213 
3.2 Optimization of the dimer-hexamer resolution 214 
 215 
In order to improve the resolution between the dimer and the hexamer peaks, the 216 
influence of the BGE pH was studied (Figure 2a). This modification can affect both 217 
electrophoretic (conformation and charge of the enzyme) and electroosmotic mobilities. 218 
When the pH increased from 7.2 to 8.2, an increase in the electroosmotic mobility was 219 
observed as expected, which induced a decrease in the migration times of the dimer and 220 
hexamer forms, despite the increase of the negative charge of the enzyme that would 221 
contribute to an increase in the absolute value of the electrophoretic mobility. 222 
Unfortunately, a pH increase from 7.2 to 8.2 resulted in a gradual decrease in the dimer-223 
hexamer resolution. When a BGE with a pH of 6.2 was tested, there was a marked 224 
decrease in the peak intensities of the enzyme (data not shown), may be due to a partial 225 
precipitation of the enzyme at a pH near its pI value. The BGE pH was therefore set at 226 
7.2 for the other experiments of the study. 227 
 228 
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Figure 2: Electropherograms of GlmS (0.76 μM) obtained with a BGE composed of (a) 230 
a sodium phosphate buffer plus 20 mM GlcN6P (100 mM ionic strength) at pH 7.2, 7.6, 231 
and 8.2 or (b) a sodium phosphate buffer plus 20 mM GlcN6P at pH 7.2 with a total 232 
ionic strength of 50, 100, or 150 mM. The GlmS aliquots were incubated for 120 min at 233 
room temperature within the BGE. Operating currents: between 22 and 65 µA. For other 234 
conditions, see Figure 1. 235 
 236 
The ionic strength of the BGE can also affect the dimer-hexamer separation, since it 237 
modifies the GlmS effective charge, its potential adsorption to the capillary wall, and 238 
the electroosmotic mobility. Figure 2b shows the obtained electrophoretic profiles using 239 
the BGEs with an ionic strength of 50, 100, and 150 mM. Table 1 presents the resulting 240 
electroosmotic and electrophoretic mobilities, the effective selectivity, the resolution, 241 
and the efficiency for the dimer and hexamer peaks. As expected, when the separation 242 
was performed with a BGE having a higher ionic strength, an increase in migration 243 
times was observed due to a significant decrease in the electroosmotic mobility. 244 
Considering the absolute value of the electrophoretic mobility of the dimer, a decrease 245 
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is observed when the ionic strength increases from 50 to 150 mM. This behavior may be 246 
explained by an increase in the condensation of cations on the surface of the enzyme, 247 
which results in a decrease in its effective charge [23]. Both led to an improved 248 
resolution between the GlmS dimer and hexamer peaks when the BGE ionic strength 249 
increased, to reach a maximum around 100 mM. This ionic strength value was selected 250 
for the rest of the study, since the effective selectivity and the efficiencies are the same 251 
at 100 or 150 mM, but a lower ionic strength contributes to reduce the Joule heating and 252 
100 mM provides maximum resolution. It is worthwhile to notice that for each tested 253 
condition in this manuscript, the voltage value was set in order to stay in the area of a 254 
linear increase in current with voltage. In that case, the rise in temperature in the 255 
capillary is not detrimental and a maximum difference value of 5°C was calculated 256 
between the set value and the temperature existing in the center of the capillary [24].  257 
 258 
Table 1. Electroosmotic mobility (µEO), electrophoretic mobility of the dimer (µep,dimer), 259 
effective selectivity (α), resolution (Rs), hexamer-dimer corrected area ratio, and efficiency (N) 260 
for the dimer and hexamer peaks obtained at different ionic strengths of the BGE at pH 7.2. The 261 
aliquots of 0.76 μM GlmS were incubated at room temperature during 120 min. Other 262 
conditions, see Figure 1. 263 
BGE ionic strength  50 mM 100 mM 150 mM 
µEO (x 10
5
 cm
2
 V
-1
 s
-1
)  41.5 38.7 36.4 
µep,dimer (x 10
5
 cm
2
 V
-1
 s
-1
)  -14.7 -13.2 -12.8 
α(dimer - hexamer)
a  - 1.1 1.1 
Rs(dimer – hexamer)
b  0 1.0 0.8 
hexamer-dimer corrected area ratio  - 1.0 1.9 
N(dimer)
c  - 8000 9000 
N(hexamer)
c  - 11000 10000 
a    /hexamer EOF dimer EOFt t t t     ( it  = migration time) 264 
b    1.177 /hexamer dimer hexamer dimerRs t t       (  = width at half height peak) 265 
c  
2
5.54 /i i iN t    266 
 267 
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The separation temperature was reduced to 15°C, in an attempt to improve the oligomer 268 
resolution, but no change in resolution was obtained (data not shown). An increase in 269 
the effective capillary length from 26.5 to 50 cm was next tested, keeping constant the 270 
other parameters. These two lengths led to analysis time of 7 and 27 min, respectively. 271 
This significant increase in migration times results both from an increase in the effective 272 
length and a decrease in the electrical field, as the voltage was kept constant. As can be 273 
observed in Table 2, the efficiencies increased with the effective capillary length as it is 274 
expected by the theory. However, the resolution between the two peaks was not 275 
improved. Antagonistic effects between the separation of the dimer and the hexamer 276 
along the capillary thanks to their different electrophoretic mobilities and the 277 
displacement of the equilibrium between the two forms may explain this particular 278 
behavior.  279 
 280 
Table 2. Effective selectivity (α), resolution (Rs), and efficiency (N) for the dimer and hexamer 281 
peaks obtained with two different effective capillary lengths. BGE: sodium phosphate buffer 282 
plus 20 mM GlcN6P at pH 7.2 (100 mM ionic strength). Hydrodynamic injection: 30 mbar × 4 s 283 
or 80 mbar × 5 s for effective length capillaries of 26.5 and 50 cm, respectively. Separation 284 
voltage, 10 kV. Analysis temperature, 15°C. The aliquots of 0.76 μM GlmS were incubated in 285 
BGE at room temperature during 120 min.  286 
Effective capillary length (l)  26.5 cm  50 cm 
l/L
a  0.76  0.85 
α(dimer - hexamer)
a  1.1  1.1 
Rs(dimer – hexamer)
b  1.1  1.0 
N(dimer)
c  8000  9000 
N(hexamer)
c  12000  17000 
a
L: total capillary length     
 287 
To study this hypothesis, the effect of the analysis time on the ratio of the corrected 288 
areas of the hexamer and dimer peaks was investigated. As can be seen in Figure 3, the 289 
proportion of the hexamer form increased with the incubation time and reached a 290 
plateau after several tens of minutes. However, the analysis time led to significant 291 
different values of the ratio of the two forms, whatever the pre-incubation time of the 292 
sample before the injection in the capillary: the longer the analysis time, the higher the 293 
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ratio of hexamer to dimer. This behavior is consistent with a displacement of the dimer-294 
hexamer equilibrium during the electrophoretic separation, despite the presence of the 295 
inhibitor in the BGE since the same solution is used for the CE analysis and the 296 
incubation step. Considering the increase in the hexamer proportion with the incubation 297 
time and the analysis time, which can be considered as an extension of the incubation 298 
time as the inhibitor is also present in the BGE, we can suggest that the kinetics of the 299 
hexamer formation is faster than its dissociation into dimer. To reinforce this 300 
hypothesis, a sample incubated for 50 min at room temperature was also analyzed with 301 
the longer capillary (50 cm effective length) at a higher temperature of analysis (35°C), 302 
but not so different from the incubation temperature value (room temperature, therefore 303 
about 10°C) and during a limited time (17 vs 50 min). In that case, the analysis time was 304 
reduced to 17 min and the ratio of the hexamer/dimer corrected areas was reduced as 305 
expected, from 1.9 to 0.7.  306 
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 307 
Figure 3: Plot of the ratio of the corrected areas of the hexamer to dimer peaks vs the 308 
incubation time for two different analysis times. Diamonds, analysis time: 7 min, 309 
effective capillary length: 26.5 cm. Squares, analysis time: 27 min, effective capillary 310 
length: 50 cm. The aliquots of 0.76 μM GlmS were incubated in the BGE at room 311 
temperature. Each condition (incubation + electrophoretic analysis) was tested 3 times. 312 
The meaning of the error bar is the highest and the lowest obtained values. For other 313 
conditions, see Table 2. 314 
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 315 
With this first CE method, other characterizations of the enzyme-inhibitor system were 316 
carried out. As an example, using a GlcN6P inhibitor concentration fixed at 20 mM, the 317 
concentration of the GlmS enzyme was varied from 0.76 to 3.8 μM, which corresponds 318 
to an inhibitor-enzyme molar ratio between 26,300 and 5,300. Figure 4a shows the ratio 319 
of the corrected areas of hexamer to dimer peaks vs the incubation time for the different 320 
ratios of the inhibitor to enzyme concentrations. The proportion of the inactive hexamer 321 
form increases with the concentration of the dimer, which is consistent with the mass 322 
action law.  323 
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Figure 4: Plots of the ratio of the corrected areas of the hexamer to dimer peaks vs the 325 
incubation time for (a) different ratios of the inhibitor and enzyme concentrations and 326 
(b) two incubation temperatures. (a) [GlcN6P] = 20 mM, [GlmS] = 0.76, 1.9, and 327 
3.8 μM, which correspond to ratios of 26,300 (diamonds), 10,500 (squares), and 5,300 328 
(triangles), respectively. Incubation at room temperature; total capillary length, 35 cm; 329 
for other separation conditions see Table 2. (b) incubation at 4°C (squares) or at room 330 
temperature (diamonds); [GlmS] = 0.76 μM and [GlcN6P] = 20 mM; total capillary 331 
14 
 
length, 58.5 cm; for other separation conditions see Table 2. Each condition was tested 332 
2 and 3 times (incubation + electrophoretic analysis) in a and b, respectively. The 333 
meaning of the error bar is the highest and the lowest obtained values. 334 
 335 
The incubation temperature was also studied: two aliquots of the GlmS enzyme were 336 
incubated with GlcN6P at 4 and 25°C, and injected at different incubation times (Figure 337 
4b). In both cases, if the hexamer/dimer ratio increases with the incubation time, the low 338 
incubation temperature seems to favor the displacement of the equilibrium to the 339 
inactive hexamer form. We can notice that the equilibrium between the dimer and 340 
hexamer forms is temperature-dependent and that some Joule heating during the 341 
separation occurs, but it may have a little impact on it since, as already said, a maximum 342 
difference value of 5°C was calculated between the set value and the temperature 343 
existing in the center of the capillary [24] and, in most cases, the value is even below 344 
2°C.  345 
 346 
3.3 Short-end CE method 347 
 348 
Since the time scale of the dimer-hexamer rearrangement kinetics is close to the 349 
analysis times previously used (7 and 27 min), a reduction of the analysis time was 350 
searched using an injection by the short-capillary end to reduce the effective length to 351 
8.5 cm. Using this CE configuration, the analysis time was reduced to less than 2.5 min 352 
(data not shown). The resolution between the dimer and hexamer peaks was slightly 353 
improved to a value of 1.2, which confirms the hypothesis of a displacement of the 354 
dimer-hexamer equilibrium during the CE separation. It is worthwhile to notice that the 355 
injected volume was reduced to 2 nL (30 mbar for 2 s) keeping a non-significant 356 
contribution of the injection step to the peak band broadening, since the injected plug 357 
length was about 1% of the effective separation length. 358 
To speed up further the analysis, the temperature was increased from 15 to 25°C and the 359 
voltage was increased as much as possible while preserving the resolution to a value of 360 
15 kV. These conditions allowed a decrease in the analysis time to 1.2 min (Figure 5). 361 
The UV spectra of the peaks attributed to the dimer and the hexamer had a maximum of 362 
absorption around 200 nm. The detection wavelength was next optimized and an 363 
improvement of the signal to noise ratio of about 15% was obtained using 192 nm 364 
instead of 200 nm. 365 
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Figure 5: Electropherogram of the GlmS enzyme (1.9 μM) obtained with a short-end 367 
injection. Electrophoretic conditions: bare-fused silica capillary, 50 μm × 35 cm (8.5 cm 368 
to the detection). BGE: sodium phosphate buffer at pH 7.2 plus 20 mM GlcN6P 369 
(100 mM ionic strength). GlmS was incubated in the BGE at 4°C for 30 min. Separation 370 
voltage: 15 kV. Analysis temperature: 25°C. Hydrodynamic injection: 30 mbar × 2 s. 371 
UV detection at 192 ± 4 nm. 372 
 373 
Using the short-end approach, the influence of the concentration of the GlcN6P 374 
inhibitor on the ratio of the corrected areas of the hexamer to dimer peaks was studied 375 
with an incubation at 4°C (Figure 6). A decrease in the GlcN6P concentration from 20 376 
to 2 mM led to a smaller conversion into the inactive hexamer form, i. e. a decrease in 377 
the inhibition effect, which agrees with the mass action law, since the GlcN6P is a 378 
product of the enzymatic reaction. At a given inhibitor concentration, as already 379 
previously observed in Figure 4b, a decrease in the incubation temperature induced an 380 
increase in the inhibition effect. Then, a smaller inhibitor effect has to be expected at 381 
physiological temperatures. It is important to note that here, even if the analysis 382 
temperature is different from the incubation temperature, it must not affect significantly 383 
the hexamer-dimer ratio as the analysis time is very short (1.2 min) compare to the 384 
incubation time (up to 300 min). 385 
This method was finally used to test three inhibitors, ADGP, A5PO, and Glc6P, each at 386 
a concentration of 10 mM in the sample and in the phosphate-based BGE at pH 7.2 and 387 
with an incubation at 4°C, which correspond to values close to the values used in this 388 
study with GlcN6P. All electropherograms show only one peak. In order to make the 389 
most correct identification possible using the migration time and to take into account the 390 
small variations of the electroosmotic flow, an internal standard was used. PTSA was 391 
selected as it has a migration time of about 2 min, has a strong absorption in UV and 392 
does not affect the profile of the GlmS peaks whatever the tested inhibitor. Table 3 393 
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presents the average, the standard deviation, and the confidence interval values of the 394 
corrected electrophoretic mobilities of the dimer and the hexamer forms obtained with 395 
the introduction of 20 mM of GlcN6P in the sample and in the BGE. The corresponding 396 
values pertaining to the single peak obtained by replacing GlcN6P by another potential 397 
inhibitor are also given. If for ADGP, it is not possible to conclude which form was 398 
present without further experiments such as spiking, the other two inhibitors allow the 399 
formation of the inactive hexamer form. These preliminary results confirm the great 400 
potential of this approach for a rapid screening of potential inhibitors. 401 
 402 
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Figure 6: Plots of the ratio of the average corrected areas of the hexamer to the dimer 404 
peaks vs the incubation time for a concentration of the GlcN6P inhibitor of 2 mM or 405 
20 mM with an incubation at room temperature or at 4°C (n=2). Diamonds, 2 mM 406 
GlcN6P and incubation at 4°C. Squares, 20 mM GlcN6P and incubation at 4°C. 407 
Triangles, 20 mM GlcN6P and incubation at room temperature. [GlmS] = 1.9 μM. 408 
Analytical conditions, see Figure 5.  409 
 410 
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Table 3. Average, standard deviation (SD), and interval values of the corrected electrophoretic mobilities (µep) of the dimer and the hexamer, 411 
obtained with 20 mM of GlcN6P in the sample and in the BGE, or of the single peak obtained with 10 mM of ADGP, A5PO or Glc6P in the 412 
sample and in the BGE. [GlmS] = 1.9 μM. Incubation between 60 and 180 min, at 4°C. PTSA was used as internal standard at a concentration of 413 
0.1 mM. Other conditions: see Figure 6. 414 
 415 
 µep(dimer)/µep(PTSA) 
(n
b
=12) 
µep(hexamer)/µep(PTSA) 
(n=12) 
µep(peak obtained with 
ADGP)/µep(PTSA) (n=4) 
µep(peak obtained with 
A5PO)/µep(PTSA) (n=5) 
µep(peak obtained with 
Glc6P)/µep(PTSA) (n=8) 
average 0.508 0.547 0.524 0.541 0.539 
SD 0.011 0.008 0.009 0.005 0.002 
confidence 
interval
a
 
0.487 - 0.529 0.531 - 0.563 0.506 - 0.542 0.532 - 0.549 0.534 - 0.544 
a
values calculated for a 95% probability 416 
b
number of repetition of the electrophoretic analysis 417 
 418 
 419 
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 420 
4. Conclusion 421 
 422 
The GlmS enzyme is characterized by an allosteric regulation involving an equilibrium 423 
between two forms: the active dimer and the inactive hexamer. For the first time, it was 424 
demonstrated that the two forms can be separated by CE after introducing GlcN6P in 425 
the sample for pre-incubation and in the BGE. A sodium phosphate based BGE plus 426 
20 mM GlcN6P at pH 7.2 and an ionic strength of 100 mM leads to the best apparent 427 
resolution between the hexamer and dimer forms. Nevertheless, the displacement of the 428 
dimer/hexamer equilibrium during the time frame of the analysis prevents any 429 
improvement of the resolution when varying the effective separation length or the 430 
analysis temperature. Therefore, the use of a short-end CE method allowed the decrease 431 
in the analysis time to about 1 min. Some parameters such as the temperature and the 432 
time of incubation and the ratio of the inhibitor and enzyme concentrations were 433 
studied. Then, it was also possible to test, very rapidly and using minute amounts, some 434 
molecules having an inhibition potential for the GlmS enzyme.  435 
436 
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